Subchronic treatment with fluoxetine attenuates effects of acute fluoxetine on female rat sexual behavior

Brain Research

Volumn 1190, Issue 1, 2008, Pages 56-64

  Sarkar, J ^a   Hiegel, C ^a   Ginis, G E ^a   Hilbun, E ^a   Uphouse, L ^a  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

Lordosis; Sexual motivation; SSRI; Subchronic

Indexed keywords

ESTRADIOL BENZOATE; FLUOXETINE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GROOMING; LONG TERM CARE; LORDOSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; WEIGHT REDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ESTROUS CYCLE; FEMALE; FLUOXETINE; NEUROSECRETORY SYSTEMS; POSTURE; RATS; RATS, INBRED F344; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SOCIAL BEHAVIOR;

RATTUS;

EID: 37549009583     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.033     Document Type: Article

References (43)

1. Bagdy G., Graf M., Anheuer Z.E., Modos E.A., and Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol. 4 (2001) 399-408
2. Basson R. The complexities of female sexual arousal disorder: potential role of pharmacotherapy. World J. Urol. 20 (2002) 119-126
3. Clark A.S., Kelton M.C., Guarraci F.A., and Clyons E.Q. Hormonal status and test condition, but not sexual experience, modulate partner preference in female rats. Horm. Behav. 45 (2004) 314-323
4. Dimmock P.W., Wyatt K.M., Jones P.W., and O'Brien P.M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356 (2000) 1131-1136
5. Drapier D., Bentue-Ferrer D., Laviolle B., Millet B., Allain H., Bourin M., and Reymann J.M. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav. Brain Res. 176 (2007) 202-209
6. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Brain Res. Rev. 15 (1990) 71-100
7. Dunn A.J., Berridge C.W., Lai Y.I., and Yachabach T.L. CRF-induced excessive grooming behavior in rats and mice. Peptides 8 (1987) 841-844
8. Fourcroy J.L. Female sexual dysfunction: potential for pharmacotherapy. Drugs 63 (2003) 1445-1457
9. Frohlich P.F., and Meston C.M. Evidence that serotonin affects female sexual functioning via peripheral mechanisms. Physiol. Behav. 71 (2000) 383-393
10. Frye C.A., and Rhodes M.E. Zaprinast, a phosphodiesterase 5 inhibitor, overcomes sexual dysfunction produced by fluoxetine, a selective serotonin reuptake inhibitor in hamsters. Neuropsychopharmacology 28 (2003) 310-316
11. Frye C.A., Petralia S.M., Rhodes M.E., and Stein B. Fluoxetine may influence lordosis of rats through effects on midbrain 3 alpha,5 alpha-THP concentrations. Ann. N.Y. Acad. Sci. 1007 (2003) 37-41
12. Fuller R.W., Wong D.T., and Robertson D.W. Fluoxetine, a selective inhibitor of serotonin uptake. Med. Res. Rev. 11 (1991) 17-34
13. Gibbs D.M., and Vale W. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res. 280 (1983) 176-179
14. Gobert A., Rivet J.M., Cistarelli L., and Millan M.J. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935. J. Neurochem. 68 (1997) 1159-1163
15. Gregorian R.S., Golden K.A., Bahce A., Goodman C., Kwong W.J., and Khan Z.M. Antidepressant-induced sexual dysfunction. Ann. Pharmacother. 36 (2002) 1577-1589
16. Hedges D.W., Brown B.L., Shwalb D.A., Godfrey K., and Larcher A.M. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. J. Psychopharmacol. 21 (2007) 102-111
17. Hines R.N., Adams J., Buck G.M., Faber W., Holson J.F., Jacobson S.W., Keszler M., McMartin K., Segraves R.T., Singer L.T., Sipes I.G., and Williams P.L. NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine. Birth Defects Res. B. Dev. Reprod. Toxicol. 71 (2004) 193-280
18. Kennedy S.H., Fulton K.A., Bagby R.M., Greene A.L., Cohen N.L., and Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can. J. Psychiatry 51 (2006) 234-242
19. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., and Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 29 (1993) 85-96
20. Kliethermes C.L., and Crabbe J.C. Pharmacological and genetic influences on hole-board behaviors in mice. Pharmacol. Biochem. Behav. 85 (2006) 57-65
21. Koch S., Perry K.W., Nelson D.L., Conway R.G., Threlkeld P.G., and Bymaster F.P. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27 (2002) 949-959
22. Kornstein S.G., Schatzberg A.F., Yonkers K.A., Thase M.E., Keitner G.I., Ryan C.E., and Schlager D. Gender differences in presentation of chronic major depression. Psychopharmacol. Bull. 31 (1995) 711-718
23. Li Q., Muma N.A., and van de Kar L.D. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J. Pharmacol. Exp. Ther. 279 (1996) 1035-1042
24. Malagie I., Trillat A.C., Jacquot C., and Gardier A.M. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur. J. Pharmacol. 286 (1995) 213-217
25. Matuszczyk J.V., Larsson K., and Eriksson E. Subchronic administration of fluoxetine impairs estrous behavior in intact female rats. Neuropsychopharmacology 19 (1998) 492-498
26. McEwen B.S., Jones K.J., and Pfaff D.W. Hormonal control of sexual behavior in the female rat: molecular, cellular and neurochemical studies. Biol. Reprod. 36 (1987) 37-45
27. Mendelson S.D. A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat. Neurosci. Biobehav. Rev. 16 (1992) 309-350
28. Montgomery S.A., Baldwin D.S., and Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J. Affect. Disord. 69 (2002) 119-140
29. Perry K.W., and Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50 (1992) 1683-1690
30. Prinssen E.P., Ballard T.M., Kolb Y., and Nicolas L.B. The effects of serotonin reuptake inhibitors on locomotor activity in gerbils. Pharmacol. Biochem. Behav. 85 (2006) 44-49
31. Raap D.K., Evans S., Garcia F., Li Q., Muma N.A., Wolf W.A., Battaglia G., and Van De Kar L.D. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J. Pharmacol. Exp. Ther. 288 (1999) 98-106
32. Shen W.W., and Hsu J.H. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int. J. Psychiatry Med. 25 (1995) 239-248
33. Simon N.M., Zalta A.K., Worthington III J.J., Hoge E.A., Christian K.M., Stevens J.C., and Pollack M.H. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress. Anxiety 23 (2006) 373-376
34. Sodersten P. Estradiol-progesterone interactions in the reproductive behavior of female rats. In: Ganten D., and Pfaff D. (Eds). Current Topics in Neuroendocrinology: Actions of Progesterone on the Brain (1981), Springer-Verlag, New York 141-174
35. Sukoff Rizzo S.J., Schechter L.E., and Rosenzweig-Lipson S. 5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats: clinical implications. Eur. Neuropsychopharmacol. 16 (2006) S345-S346
36. Tao R., Fray A., Aspley S., Brammer R., Heal D., and Auerbach S. Effects on serotonin in rat hypothalamus of d-fenfluramine, aminorex, phentermine and fluoxetine. Eur. J. Pharmacol. 445 (2002) 69-81
37. Temel Y., Helmy A., Pinnock S., and Herbert J. Effect of serotonin depletion on the neuronal, endocrine and behavioural responses to corticotropin-releasing factor in the rat. Neurosci. Lett. 338 (2003) 139-142
38. Uphouse L. Female gonadal hormones, serotonin, and sexual receptivity. Brain Res. Rev. 33 (2000) 242-257
39. Uphouse L., Caldarola-Pastuszka M., and Montanez S. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior. Neuropharmacology 31 (1992) 969-981
40. Uphouse L., Hensler J.G., Sarkar J., and Grossie B. Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats. Brain Res. 1072 (2006) 79-90
41. Van de Kar L.D., Raap D.K., Battaglia G., Muma N.A., Garcia F., and DonCarlos L.L. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors. Neuropharmacology 43 (2002) 45-54
42. White S., and Uphouse L. Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior. Horm. Behav. 45 (2004) 201-208
43. Zar J. Biostatistical Analysis. 4th edn. (1999), Prentice-Hall, Englewood Cliffs, NJ